Moxifloxacin-associated neutropenia

Berk V., Demiraslan H., Berk E., Karaca H., İNANÇ M., BOZKURT O., ...Daha Fazla

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, cilt.45, sa.5, ss.415-416, 2013 (SCI-Expanded) identifier

Özet

A 32-y-old woman presented with pneumonia. Treatment was started with moxifloxacin. On day 2 of moxifloxacin treatment the patient developed neutropenia. After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adverse effect in patients treated with moxifloxacin.

A 32-y-old woman presented with pneumonia. Treatment was started with moxifloxacin. On day 2 of moxifloxacin treatment the patient developed neutropenia. After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adverse effect in patients treated with moxifloxacin.